160 related articles for article (PubMed ID: 37824592)
1. Clinical performance validation of the STANDARD G6PD test: A multi-country pooled analysis.
Adissu W; Brito M; Garbin E; Macedo M; Monteiro W; Mukherjee SK; Myburg J; Alam MS; Bancone G; Bansil P; Pal S; Sharma A; Zobrist S; Bryan A; Chu CS; Das S; Domingo GJ; Hann A; Kublin J; Lacerda MVG; Layton M; Ley B; Murphy SC; Nosten F; Pereira D; Price RN; Talukdar A; Yilma D; Gerth-Guyette E
PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011652. PubMed ID: 37824592
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
[TBL] [Abstract][Full Text] [Related]
4. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
[TBL] [Abstract][Full Text] [Related]
5. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
[TBL] [Abstract][Full Text] [Related]
7. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
8. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
[TBL] [Abstract][Full Text] [Related]
9. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
10. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre, Eastern Ethiopia.
Shenkutie TT; Nega D; Hailu A; Kepple D; Witherspoon L; Lo E; Negash MT; Adamu A; Gebremichael SG; Gidey B; Tasew G; Feleke SM; Kebede T
Malar J; 2022 Sep; 21(1):260. PubMed ID: 36076204
[TBL] [Abstract][Full Text] [Related]
12. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
Milligan R; Daher A; Graves PM
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
[TBL] [Abstract][Full Text] [Related]
13. Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.
Pal S; Myburgh J; Bansil P; Hann A; Robertson L; Gerth-Guyette E; Ambler G; Bizilj G; Kahn M; Zobrist S; Manis MR; Styke NA; Allan V; Ansbro R; Akingbade T; Bryan A; Murphy SC; Kublin JG; Layton M; Domingo GJ
PLoS One; 2021; 16(9):e0257560. PubMed ID: 34543346
[TBL] [Abstract][Full Text] [Related]
14. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rodrigo C; Rajapakse S; Fernando D
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
[TBL] [Abstract][Full Text] [Related]
15. Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
Pfeffer DA; Ley B; Howes RE; Adu P; Alam MS; Bansil P; Boum Y; Brito M; Charoenkwan P; Clements A; Cui L; Deng Z; Egesie OJ; Espino FE; von Fricken ME; Hamid MMA; He Y; Henriques G; Khan WA; Khim N; Kim S; Lacerda M; Lon C; Mekuria AH; Menard D; Monteiro W; Nosten F; Oo NN; Pal S; Palasuwan D; Parikh S; Pitaloka Pasaribu A; Poespoprodjo JR; Price DJ; Roca-Feltrer A; Roh ME; Saunders DL; Spring MD; Sutanto I; Thriemer K; Weppelmann TA; von Seidlein L; Satyagraha AW; Bancone G; Domingo GJ; Price RN
PLoS Med; 2020 May; 17(5):e1003084. PubMed ID: 32407380
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness Analysis of Sex-Stratified
Devine A; Howes RE; Price DJ; Moore KA; Ley B; Simpson JA; Dittrich S; Price RN
Am J Trop Med Hyg; 2020 Jul; 103(1):394-403. PubMed ID: 32372747
[TBL] [Abstract][Full Text] [Related]
17. Implementation of G6PD testing and primaquine for
Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
[TBL] [Abstract][Full Text] [Related]
18. Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria.
Ley B; Alam MS; Satyagraha AW; Phru CS; Thriemer K; Tadesse D; Shibiru T; Hailu A; Kibria MG; Hossain MS; Rahmat H; Poespoprodjo JR; Khan WA; Simpson JA; Price RN
PLoS Negl Trop Dis; 2022 May; 16(5):e0010406. PubMed ID: 35544453
[TBL] [Abstract][Full Text] [Related]
19. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
[TBL] [Abstract][Full Text] [Related]
20. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests.
Bancone G; Chu CS; Chowwiwat N; Somsakchaicharoen R; Wilaisrisak P; Charunwatthana P; Bansil P; McGray S; Domingo GJ; Nosten FH
Am J Trop Med Hyg; 2015 Apr; 92(4):818-824. PubMed ID: 25646252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
